Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine versus dexmedetomidine + ketamine premedication in children undergoing tonsillectomy
ACTRN12616001522404Phase 3Completed
- Sponsor
- Yusheng Pharmaceutical
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in tonsillitis comparing Dexmedetomidine with Dexmedetomidine + Ketamine (2 arms). Primary endpoint: Sedation score. Started Jan 2017; status: completed.
02
Drugs
dexmedetomidineketamine
03
Conditions
tonsillitis
Beyond the preview
Go deeper on ACTRN12616001522404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001522404.